A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies.
- Resource Type
- Article
- Authors
- Segura-Aguilar, Juan; Mannervik, Bengt
- Source
- Antioxidants; Mar2023, Vol. 12 Issue 3, p673, 17p
- Subject
- PARKINSON'S disease
DOPAMINERGIC neurons
GENETIC regulation
DOPAMINE receptors
ANIMAL models in research
GLUTATHIONE transferase
OLDER people
- Language
- ISSN
- 20763921
Copyright of Antioxidants is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)